Riskpilot← Back to searchSign inGet full accessENEDRIA AS
ASActiveOrg 919166142Energivegen 20, 4056 TanangerResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20172 employees
Revenue 2024
NOK 363K
-39% vs 2023
EBITDA margin
102.4%
+150% vs 2023
Equity ratio
50.3%
Financial strength
Net profit 2024
NOK -929K
-3% vs 2023
| Revenue | NOK 363K | -39% |
| EBITDA | NOK 372K | +150% |
| Net profit | NOK -929K | -3% |
| Total assets | NOK 14,8M | +14% |
| Equity | NOK 7,4M | -11% |
| Employees | 2 | — |
Legal name
ENEDRIA AS
Org number
919166142
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20. juni 2017
Share capital
NOK 87 082
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og ett styremedlem i fellesskap.
Company purpose
Salg og produksjon av kosttilskudd og legemiddel basert på marine ingredienser.
Address
Energivegen 20, 4056 Tananger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 58 | 314 | 220 | 599 | 363 |
| Staff expenses | −0 | −0 | −1 | −169 | −952 | −349 | −529 | −17 |
| EBITDA | −6 | −9 | −60 | −496 | −1 640 | −463 | −748 | 372 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −127 | −153 | −1 322 |
| EBIT | −6 | −9 | −60 | −496 | −1 640 | −590 | −901 | −950 |
| Net financials | 0 | 0 | 2 | 4 | −2 | −3 | 0 | 21 |
| Profit before tax | −6 | −9 | −57 | −492 | −1 643 | −593 | −901 | −929 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −6 | −9 | −57 | −492 | −1 643 | −593 | −901 | −929 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 95 | 6 086 | 7 334 | 10 432 | 9 851 | 10 715 | 12 947 | 14 784 |
| Equity | 18 | 6 052 | 5 994 | 8 502 | 6 860 | 7 267 | 8 366 | 7 437 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 77 | 35 | 1 340 | 1 930 | 2 991 | 3 448 | 4 581 | 7 347 |
| Total debt | 77 | 35 | 1 340 | 1 930 | 2 991 | 3 448 | 4 581 | 7 347 |
EBITDA margin
102.4%
This company
15.8%
Market median
+548% vs market
20172024
Equity ratio
50.3%
This company
38.2%
Market median
+32% vs market
20172024
Return on equity
-12.5%
This company
18.4%
Market median
-168% vs market
20172024
Net profit margin
-255.6%
This company
8.1%
Market median
-3256% vs market
20172024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20172024
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GK Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2026 | — | — | |
| Chairman | 2026 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Habu Holding As | Company | 30.9% | 30.9% | 2023 |
| Individual | 22.2% | 22.2% | 2024 | |
Rosi Charni As | Company | 9.7% | 9.7% | 2023 |
| Individual | 7.9% | 7.9% | 2024 | |
Priforsk Partners As | Company | 7.4% | 7.4% | 2023 |
| Individual | 4.5% | 4.5% | 2023 | |
| Individual | 3.8% | 3.8% | 2023 | |
| Individual | 2.7% | 2.7% | 2023 | |
| Individual | 2.3% | 2.3% | 2023 | |
Dahle Holding As | Company | 2.2% | 2.2% | 2023 |
Grunnfjellet As | Company | 2.0% | 2.0% | 2023 |
| Individual | 2.0% | 2.0% | 2022 | |
| Individual | 2.0% | 2.0% | 2022 | |
| Individual | 1.9% | 1.9% | 2023 | |
Cuben West As | Company | 1.6% | 1.6% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ENEDRIA AS 
MITOMED ASBoard members of ENEDRIA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gaute Kolnes Steinkopf | Chief Executive Officer | 0 companies |
| Nils Øyvind Berge | Board of Directors | 0 companies |
| Eimund Sletten | Chairman | 0 companies |
| Vladimir Wendl Ibarra | Chairman | 0 companies |
| Terje Nyman | Board of Directors | 0 companies |
| Bjørn Tore Langeland | Board of Directors | 0 companies |
| Sturla Sand | Board of Directors | 0 companies |